Concepedia

Thomas Hoock

TH

9

Publications

773

Citations

9

H-Index

1989

Active since

Affiliations

Vertex Pharmaceuticals (United States)(Current)

Tufts University

Thomas Hoock is an author at Vertex Pharmaceuticals (United States) specializing in medicine, drug discovery, and pharmacology.

Top concepts

Publications per year

1989–2015

9

Publications

9

Beta actin and its mRNA are localized at the plasma membrane and the regions of moving cytoplasm during the cellular response to injury.

Thomas Hoock, Patricia M. Newcomb, Ira M. Herman · The Journal of Cell Biology · 1991 · 215 citations · Full text

, , +23

Functional sorting of actin isoforms in microvascular pericytes.

David DeNofrio, Thomas Hoock, Ira M. Herman · The Journal of Cell Biology · 1989 · 136 citations · Full text

, , +17

A Randomized, Double‐Blind, Placebo‐Controlled, Twelve‐Week, Dose‐Ranging Study of Decernotinib, an Oral Selective JAK‐3 Inhibitor, as Monotherapy in Patients With Active Rheumatoid Arthritis

Roy Fleischmann, Nemanja Damjanov, Alan Kivitz et al. · Arthritis & Rheumatology · 2014 · 108 citations

Discovery of VX-509 (Decernotinib): A Potent and Selective Janus Kinase 3 Inhibitor for the Treatment of Autoimmune Diseases

Luc J. Farmer, Mark W. Ledeboer, Thomas Hoock et al. · Journal of Medicinal Chemistry · 2015 · 87 citations

, , +16

Isoforms of Ankyrin-3 That Lack the NH2-terminal Repeats Associate with Mouse Macrophage Lysosomes

Thomas Hoock, Luanne L. Peters, Samuel E. Lux · The Journal of Cell Biology · 1997 · 72 citations · Full text

Rows per page

1–5 of 9